P R E S S R E L E A S E
LINEBERRY RESEARCH ASSOCIATES CELEBRATES ONE YEAR ANNIVERSARY
Research Triangle Park, NC, July 1, 1996 -- Lineberry Research Associates (LRA), a pharmaceutical research and consulting firm, marked its one year anniversary today and announced the appointment of several new staff members: Mark Cierpial, Ph.D. as Senior Clinical Research Scientist, Connie Douglas, M.S. as Senior Clinical Research Associate, and Kelly Abernathy as Clinical Research Associate.
"The expansion of our staff is a testament to LRAs continued growth," said Charles G. Lineberry, Ph.D., President of LRA. "These appointments ensure our future success and strengthen LRAs ability to provide a wide range of services to our diverse roster of pharmaceutical and biotechnology clients."
Dr. Cierpial joins LRA with a strong background in clinical research after involvement in the clinical development of therapies for psychiatric and neurological diseases at Glaxo Wellcome Inc. Previously, he studied behavioral neurobiology and neuroimmunology for five years as part of his NIH-funded postdoctoral training.
Ms. Douglas comes to LRA after 16 years of laboratory and clinical research experience in the pharmaceutical industry. She was most recently a senior monitor at an area contract research organization. Prior to that, Ms. Douglas spent 10 years in CNS Clinical Research at Burroughs Wellcome Co. She brings extensive clinical monitoring experience to LRA.
Ms. Abernathy joins LRA with a solid record of superior academic performance. She earned a B.S. in Biology at Meredith College where she excelled scholastically and demonstrated leadership skills.
"The comprehensive knowledge and expertise of our people is one of our greatest assets," added Cathy Frieden Lineberry, Vice President, Marketing and Business Development. "LRA continues to succeed by fulfilling the needs of our clients. As we celebrate our first anniversary, LRA is poised for the future with an experienced team of drug development experts and a growing client base."
Lineberry Research Associates is a full-service contract research organization that provides complete development capabilities, from IND application to NDA approval and post-marketing, with particular expertise in CNS, anesthesia and analgesia. In addition to managing clinical trials, LRA differentiates itself by providing its pharmaceutical and biotechnology clients with high-level scientific and regulatory consulting services and proven expertise in scientific writing and communications.